Analysis of the Emerging Disease Landscape - COVID-19 - May 2020
The epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.
Scope
- Global epidemiology metrics and trends
- Snapshot of epidemiological trends to date in the top three most-affected countries
- An overview of the pipeline for antivirals and vaccines
- of available efficacy data
- An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
- Highlights in deal-making trends, particularly public-private partnerships
- Spotlight on social media coverage
Reasons to Buy
- Understand the global epidemiology of COVID-19
- Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
- Access an overview of the pipeline for therapeutics and vaccines
- Stay up to date on available efficacy data for pipeline-stage products
- View the clinical trials landscape by across key attributes
- Get up to speed on highlights in deal-making trends, particularly public-private partnerships
- Monitor top trends in social media coverage
Disease Background
Epidemiology
Pipeline Overview
Clinical Trials
Deal-Making Trends
Social Media Trends
Key Findings
Appendix
Covetrus Strategic SWOT Analysis Performance Capabilities Goals Strategies
This report is part of the Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the development
View Report2022 Whats Next for Pharma Innovation?--Emerging Technologies, Pipeline and Clinical Trials Review, Competitive SWOT Analysis, Partnering Deals
This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation
View ReportAnalysis of The Taiwanese EMS Industrys Net Zero Emissions Strategy (pre-order)
The international community has reached a consensus on achieving net-zero emissions by 2050. The European Union (EU) and the US markets are set to introduce carbon border adjustment mechanisms next
View Report2022 Recap and 2023 Development of the Global IC Packaging and Testing Industry
In 2022, the semiconductor industry continued to grapple with weak consumption momentum in major economies, primarily due to adverse factors such as high inflation rates and the Russia-Ukraine war. Since
View ReportFill The Form For Sample Request
